A Single-arm, Phase II, Multi-center Clinical Trial of Sintilimab During the Perioperative Period in Patients With Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

This study is a single-arm, multi-center Phase II clinical trial. As depicted in the following study design diagram, its objective is to observe and assess the efficacy and safety of sintilimab during the perioperative period in patients with resectable locally advanced head and neck squamous cell carcinoma.

NCT Number	NCT07379424
Lead Sponsor	chen chao Professor
Conditions	Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma
Enrollment	37 participants
Start Date	2026-01-28
Primary Completion	2027-08-25 (estimated)
Study Completion	2028-08-25 (estimated)
Updated on ClinicalTrials.gov	2026-01-30